论文部分内容阅读
目的分析高血压脑卒中患者脑微出血的临床诊断方法 ,探讨相应的治疗方法及疗效。方法回顾性分析57例高血压脑卒中合并脑微出血患者的临床资料,对其临床诊断情况进行总结。所有患者均根据实际病情,开展对症治疗,观察治疗效果。结果核磁共振加权成像结果显示:57例患者脑微出血病灶边界清晰,所有患者均得到明确诊断;57例合并脑微出血患者中,每例患者至少发现1~30个微出血病灶,共319个;基底节区170个(53.29%),丘脑61个(19.12%),脑干59个(18.50%),小脑24个(7.52%),其他位置5个(1.57%),基底节区微出血病灶最多;根据患者实际病情,严格按照高血压脑卒中内科诊疗方法对患者实施对症治疗,本组未出现死亡病例,且预后良好。结论脑微出血是高血压脑卒中(脑出血)的主要危险因素,临床在为高血压脑卒中患者进行诊断治疗时,要明确微出血病灶,并开展对症治疗,使高血压脑卒中患者诊治工作更具针对性。
Objective To analyze the clinical diagnosis of cerebral micro-hemorrhage in patients with hypertensive stroke and to explore the corresponding treatment and efficacy. Methods The clinical data of 57 patients with hypertensive stroke complicated with cerebral micro-hemorrhage were retrospectively analyzed, and their clinical diagnosis was summarized. All patients according to the actual condition, to carry out symptomatic treatment, observe the effect of treatment. Results The results of MRI showed that the boundary of brain micro-hemorrhage in 57 patients was clear and all the patients had a definite diagnosis. Among the 57 patients with cerebral micro-hemorrhage, at least 1 ~ 30 micro-hemorrhagic lesions were found in each patient, with a total of 319 (53.29%) in the basal ganglia, 61 (19.12%) in the thalamus, 59 (18.50%) in the brainstem, 24 (7.52%) in the cerebellum and 5 (1.57%) in other locations. According to the patient’s actual condition, the patients were treated with symptomatic treatment strictly according to the medical diagnosis and treatment of hypertensive stroke. No deaths occurred in this group and the prognosis was good. Conclusions Cerebral microbleeding is a major risk factor for stroke (intracerebral hemorrhage) in hypertensive patients. In clinical diagnosis and treatment of hypertensive stroke patients, micro-hemorrhagic lesions should be identified and symptomatic treatment should be carried out so that diagnosis and treatment of hypertensive stroke patients More targeted.